WHO ICTRP trial
Pharmacological clinical study on NESP 5 microgram(injection plastic syringe)
JPRN-UMIN000013805 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000013805 |
|---|---|
| Public title | Pharmacological clinical study on NESP 5 microgram(injection plastic syringe) |
| Scientific title | Pharmacological clinical study on NESP 5 microgram(injection plastic syringe) - Pharmacological clinical study on NESP 5 microgram(injection plastic syringe) |
| Primary sponsor | Medical Corporation Showakai Ikegami General Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | adult patients on hemodialysis |
| Interventions | A single dose of NESP 5 microgram will be intravenously administered after hemodialysis to patients not receiving any ESAs for a period of 3 to 13 days. Pharmacokinetic data will be collected for 8 days (168 hours) after the study… |
| Registration date | Apr 26, 2014 |
| Target size | 6 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: